Lupin launches chronic angina treatment drug in the US

The newly launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences' Ranexa ER tablets, Lupin said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2GPaDDK
via IFTTT

0 comments:

Post a Comment